Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice-Reference-Cited by-同舟云学术

Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice

Published:2014-12 Issue:12 Volume:4 Page:e264-e264
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Muto H,Sakata-Yanagimoto M,Nagae G,Shiozawa Y,Miyake Y,Yoshida K,Enami T,Kamada Y,Kato T,Uchida K,Nanmoku T,Obara N,Suzukawa K,Sanada M,Nakamura N,Aburatani H,Ogawa S,Chiba S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201483.pdf

Reference52 articles.

1. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930–935.

2. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y . Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466: 1129–1133.

3. Branco MR, Ficz G, Reik W . Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 2011; 13: 7–13.

4. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468: 839–843.

5. Kriukiene E, Liutkeviciute Z, Klimasauskas S . 5-Hydroxymethylcytosine–the elusive epigenetic mark in mammalian DNA. Chem Soc Rev 2012; 41: 6916–6930.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type;Modern Pathology;2024-07

2. TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer;Annual Review of Immunology;2024-06-28

3. Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma‑not otherwise specified: A case report;Oncology Letters;2024-05-28

4. Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches;The Innovation Medicine;2024

5. Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches;The Innovation Medicine;2024